{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:17:50Z","timestamp":1790194670432,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.lpm.2019.07.014","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T22:06:02Z","timestamp":1573077962000},"page":"1092-1100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Les femmes \u00e0 haut risque de cancer du sein\u00a0: quelle attitude\u00a0?"],"prefix":"10.1016","volume":"48","author":[{"given":"Doriane","family":"Livon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nogu\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2019.07.014_bib0140","series-title":"\u00c9tude \u00e0 partir des registres des cancers du r\u00e9seau Francim. R\u00e9sultats pr\u00e9liminaires. Synth\u00e8se","first-page":"20","article-title":"Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990\u00a0et 2018","author":"Defossez","year":"2019"},{"key":"10.1016\/j.lpm.2019.07.014_bib0145","unstructured":"Haute Autorit\u00e9 de sant\u00e9. D\u00e9pistage du cancer du sein en France: identification des femmes \u00e0 haut risque et modalit\u00e9s de d\u00e9pistage. Synth\u00e8se. Mars 2014."},{"key":"10.1016\/j.lpm.2019.07.014_bib0150","unstructured":"Institut national du cancer. (Oncog\u00e9n\u00e9tique en 2016\/consultations, laboratoires et suivi, INCa, d\u00e9cembre 2017."},{"issue":"3","key":"10.1016\/j.lpm.2019.07.014_bib0155","first-page":"219","article-title":"Identification et prise en charge des pr\u00e9dispositions aux cancers du sein et de l\u2019ovaire","volume":"91","author":"Eisinger","year":"2004","journal-title":"Bull Cancer"},{"key":"10.1016\/j.lpm.2019.07.014_bib0160","unstructured":"Institut national du cancer. \u00a9 Cancer de l\u2019ovaire et inhibiteur de PARP: parcours des patientes en g\u00e9n\u00e9tique oncologique, collection Outils pour la pratique, INCa, janvier 2017."},{"key":"10.1016\/j.lpm.2019.07.014_bib0165","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2019.07.014_bib0170","unstructured":"L\u00e9gifrance - Loi n\u030a 2004-800\u00a0du 6\u00a0ao\u00fbt 2004\u00a0relative \u00e0 la bio\u00e9thique https:\/\/www.legifrance.gouv.fr\/affichTexte.do?cidTexte=JORFTEXT000000441469."},{"key":"10.1016\/j.lpm.2019.07.014_bib0175","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bulcan.2018.08.003","article-title":"Recommandations fran\u00e7aises du Groupe g\u00e9n\u00e9tique et cancer pour l\u2019analyse en panel de g\u00e8nes dans les pr\u00e9dispositions h\u00e9r\u00e9ditaires au cancer du sein ou de l\u2019ovaire","volume":"105","author":"Moretta","year":"2018","journal-title":"Bull Cancer"},{"key":"10.1016\/j.lpm.2019.07.014_bib0180","unstructured":"L\u00e9gifrance - D\u00e9cret n\u030a 2013-527\u00a0du 20\u00a0juin 2013\u00a0relatif aux conditions de mise en \u0153uvre de l\u2019information de la parent\u00e8le dans le cadre d\u2019un examen des caract\u00e9ristiques g\u00e9n\u00e9tiques \u00e0 finalit\u00e9 m\u00e9dicale https:\/\/www.legifrance.gouv.fr\/affichTexte.do?cidTexte=JORFTEXT000027592003."},{"issue":"5182","key":"10.1016\/j.lpm.2019.07.014_bib0185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"issue":"6559","key":"10.1016\/j.lpm.2019.07.014_bib0190","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.lpm.2019.07.014_bib0195","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of Breast Ovarian, and contralateral breast cancer for BRCA1\u00a0and BRCA2\u00a0mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2019.07.014_bib0200","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"NEJM"},{"key":"10.1016\/j.lpm.2019.07.014_bib0205","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1053\/gast.2001.29611","article-title":"Incidence of gastric cancer and breast cancer in CDH1 (E-Cadherin) mutation carriers from hereditary diffuse gastric cancer families","volume":"121","author":"Pharoah","year":"2001","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.lpm.2019.07.014_bib0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","article-title":"Hereditary diffuse gastric cancer syndrome: CDH1\u00a0mutations and beyond","volume":"1","author":"Hansford","year":"2015","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.lpm.2019.07.014_bib0215","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lpm.2019.07.014_bib0220","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jmedgenet-2012-101339","article-title":"High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome","volume":"50","author":"Bubien","year":"2013","journal-title":"J Med Genet"},{"issue":"21","key":"10.1016\/j.lpm.2019.07.014_bib0225","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni Syndrome From TP53\u00a0Mutation Carrier","volume":"33","author":"Bougeard","year":"2015","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.lpm.2019.07.014_bib0230","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53\u00a0mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.lpm.2019.07.014_bib0235","unstructured":"Institut national du cancer. \u00ab\u00a0Principales recommandations de prise en charge des femmes porteuses d\u2019une mutation BRCA1ou BRCA2\u00a0\u00bb Avril 2017 \u00a9 \/Th\u00e9saurus - Femmes porteuses d\u2019une mutation de BRCA1\u00a0ou BRCA2 \/D\u00e9tection pr\u00e9coce du cancer du sein et des annexes et strat\u00e9gies de r\u00e9duction du risque, Collection recommandations et r\u00e9f\u00e9rentiels, INCa, avril 2017."},{"issue":"10","key":"10.1016\/j.lpm.2019.07.014_bib0240","first-page":"979","article-title":"Estimation du risque individuel de cancer du sein\u00a0: int\u00e9r\u00eat et limites des mod\u00e8les de calcul de risque","volume":"96","author":"De Pauw","year":"2009","journal-title":"Bull Cancer"},{"key":"10.1016\/j.lpm.2019.07.014_bib0245","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/bjc.2013.730","article-title":"BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour","volume":"110","author":"Lee","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lpm.2019.07.014_bib0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10689-017-0014-x","article-title":"Use of the BOADICEA Web Application in clinical practice:appraisals by clinicians from various countries","volume":"17","author":"Br\u00e9dart","year":"2018","journal-title":"Fam Cancer"},{"key":"10.1016\/j.lpm.2019.07.014_bib0255","unstructured":"University of Cambridge Centre for Cancer Genetic Epidemiology https:\/\/ccge.medschl.cam.ac.uk\/boadicea\/."},{"key":"10.1016\/j.lpm.2019.07.014_bib0260","first-page":"130","article-title":"Haut risque de cancer du sein\u00a0: une RCP d\u2019\u00e9valuation et de recommandations","volume":"2","author":"Moretta","year":"2016","journal-title":"Innov Ther Oncol"},{"issue":"4","key":"10.1016\/j.lpm.2019.07.014_bib0265","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10689-016-9910-8","article-title":"An investigation of the factors effecting high-risk individuals\u2019 decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC)","volume":"15","author":"Hallowell","year":"2016","journal-title":"Fam Cancer"},{"key":"10.1016\/j.lpm.2019.07.014_bib0270","unstructured":"L\u00e9gifrance - D\u00e9cret n\u030a 2016-1185\u00a0du 30\u00a0ao\u00fbt 2016\u00a0relatif \u00e0 la participation des assur\u00e9s pour les frais li\u00e9s au d\u00e9pistage sp\u00e9cifique du cancer du sein en cas de risque \u00e9lev\u00e9 https:\/\/www.legifrance.gouv.fr\/eli\/decret\/2016\/8\/30\/AFSS1613779D\/jo\/texte."}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498219303021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498219303021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T17:38:45Z","timestamp":1576604325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498219303021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0755498219303021"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2019.07.014","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les femmes \u00e0 haut risque de cancer du sein\u00a0: quelle attitude\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2019.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}